Mark Kaminski

14.5k citations
193 papers · 8.1k · 1 hit paper · h-index 44

Impact in

Papers in

Mark Kaminski

186 papers receiving 7.9k citations

Mark Kaminski's Hit Papers

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era 2013 · 620 citations
6200+4+8Years since publication200400600

Peers

Mark Kaminski
Comparison fields: 5 of 143
  • Pathology and Forensic Medicine 3.7k
  • Radiology, Nuclear Medicine and Imaging 3.1k
  • Genetics 1.1k
  • Oncology 2.2k
  • Hematology 733
Replace T. Andrew Lister with:
T. Andrew Lister United Kingdom
Edi Brogi United States
Patrick Therasse Belgium
Ruth L. Katz United States
Stephen J. Schuster United States
Jan Bogaerts Belgium
Sunil Badve United States
E. Eisenhauer Canada
André Goy United States
Lalitha Shankar United States
Mark Kaminski relative to T. Andrew Lister United Kingdom T. Andrew Lister's profile →
Citations per field
00.5×4.1×
T. Andrew Lister · 1×
Citations per year

Countries citing papers authored by Mark Kaminski

Since Specialization
Citations

This map shows the geographic impact of Mark Kaminski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kaminski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kaminski more than expected).

Fields of papers citing papers by Mark Kaminski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kaminski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kaminski. The network helps show where Mark Kaminski may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Kaminski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Kaminski Line = papers co-authored together Mark Kaminski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Hit paper breakdown →
2013620
2 2005495
3 2001443
4 1993441
5 2000400
6 1996327
7 2012310
8 2000273
9 1994207
10 2019193
11 2005183
12 1987141
13 2008135
14 2014133
15 2009132
16 2012122
17 1992121
18 1986110
19 1991108
20 1985105

About Mark Kaminski

Mark Kaminski is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Artificial Intelligence and Genetics, having authored 193 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (87 papers), Radiopharmaceutical Chemistry and Applications (37 papers), Chronic Lymphocytic Leukemia Research (27 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), Semantic Web and Ontologies (23 papers), Viral-associated cancers and disorders (20 papers), Logic, Reasoning, and Knowledge (17 papers) and Multiple Myeloma Research and Treatments (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.7k citations), Radiology, Nuclear Medicine and Imaging (3.1k citations), Genetics (1.1k citations), Oncology (2.2k citations) and Hematology (733 citations). Mark Kaminski has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Richard L. Wahl, Kenneth Zasadny, Isaac R. Francis, Denise Regan, Charles W. Ross, Andrew D. Zelenetz, Stewart Kroll, Judith Estes, Susan J. Fisher and Melissa Tuck. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Immunology, Clinical Cancer Research and Cancer Biotherapy and Radiopharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact